The public record for this applicant is narrow and specific. A single 510(k) entry, K260470, is linked to Shenzhen Brav Electronic Technologies Co., Ltd., and that entry carries a Substantially Equivalent decision dated 2026-10-01. The device is listed under product code DXN, regulation number 870.1130, and the classification name System, Measurement, Blood-Pressure, Non-Invasive, placing it in Class 2 with a Cardiovascular advisory committee. The submission was received on 2026-02-12 and reviewed through the Traditional pathway rather than a third-party review. [1][4][8]
The cleared device and its model designations
K260470 covers an Electronic Blood Pressure Monitor identified by a long list of model numbers in the device name itself: BP-204C, BP-204A, BP-215, BP-203C, BP-205A, BP-201C, BP-217, BP-202C, BP-202, BP-205, BP-205B and BP-206. The same record lists the device under the classification name System, Measurement, Blood-Pressure, Non-Invasive, with device class 2 and regulation number 870.1130. One independent index describes the device as measuring blood pressure and pulse rate using the oscillometric method, and that description is attributed to that publisher rather than to the applicant. [1][3][4]
The model designations are the only product identities documented in the public documents. Nothing in the record describes housing, cuff design, memory functions, connectivity, power source or intended care setting beyond the classification and the oscillometric description attributed to Innolitics. The FCC entry for grantee code 2A39J and product code BP206 concerns an Electronic Blood Pressure Monitor by the same named company, with a latest application date of 2026-09-23, but it is a radio-equipment filing and not a statement about the FDA-cleared device's features. [3][9]
Submission dates and review pathway
The 510(k) was received by FDA on 2026-02-12 and decided on 2026-10-01, a Traditional clearance with no third-party review. The applicant is recorded at a Shenzhen address in the filing data, with contact name JinRan Bleu; that address is a correspondence detail in the FDA record and is not presented here as a corporate headquarters. The decision description is Substantially Equivalent, and the statement or summary field indicates a Summary was prepared. [1][4]
One aggregator states that the clearance followed a 231-day FDA review, a figure that publisher derived from the received and decision dates. The same source dates its data update to 2026-11-06. These are third-party computations and timestamps, not FDA statements, and they are reported as that publisher's own presentation. [6]
How the portfolio is counted
The supplied collection contains one linked record, a 510(k), and its decision count is one Substantially Equivalent entry; the sample decision count for the explicitly smaller record sample is likewise one. These figures describe the supplied filings as of the snapshot date and are not a measure of total company sales, total portfolio or safety performance. A separate company page states that FDA's public records list three 510(k) clearances under this name as of 2026-11-17, with the most recent dated 2026-10-01; that count comes from that publisher and is not reconciled with the single linked record here. [1][7]
No premarket approval, De Novo grant or recall appears in the public information for this applicant. The absence of recall entries in the sample is a property of the sample, not evidence about the company's postmarket history. [1]
Identity and attribution boundaries
The legal applicant name appears consistently across the FDA-derived records as Shenzhen Brav Electronic Technologies Co., Ltd., with country code CN. One company-tracking page notes that spellings are joined only when they reduce to the same name or a reviewed source names the same company, and that sharing an FDA establishment number is not sufficient for joining entities; that methodology belongs to that publisher. No parent, subsidiary, brand owner or commercial partner is verified in the public documents, and no website, customer list or certification is documented. [1][7]
Product code DXN is shared with other applicants; one index shows a separate clearance, K260670, for a different company's electronic blood pressure monitor. Sharing a product code therefore does not establish any relationship between the two firms. [4]

